Distinct cellular responses differentiating alcohol- and hepatitis C virus-induced liver cirrhosis

Virology Journal

Volumn 3, Issue , 2006, Pages

  Lederer, Sharon L ^a   Walters, Kathie Anne ^a   Proll, Sean ^a   Paeper, Bryan ^a   Robinzon, Shahar ^a,b   Boix, Loreto ^c   Fausto, Nelson ^a   Bruix, Jordi ^c   Katze, Michael G ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIVIRUS AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ANTIVIRAL ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA FINGERPRINTING; DNA MICROARRAY; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE INDUCTION; HEPATITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; INNATE IMMUNITY; LIPID METABOLISM; LIVER BIOPSY; LIVER CIRRHOSIS; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MALE; OXIDATIVE STRESS;

CYTOKINES; GENE EXPRESSION PROFILING; HEPATITIS C; HUMANS; IMMUNITY, INNATE; LIVER; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC;

HEPATITIS C VIRUS;

EID: 33845356932     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-3-98     Document Type: Article

References (57)

1. Koike K: Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH. Hepatol Res 2005, 33(2):145-150.
2. Alter HJ, Seeff LB: Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 2000, 20:17-35.
3. Hines IN, Wheeler MD: Recent advances in alcoholic liver disease III. Role of the innate immune response in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol 2004, 287:G310-G314.
4. Saito H, Ishii H: Recent understanding of immunological aspects in alcoholic hepatitis. Hepatol Res 2004, 30:193-198.
5. Lieber CS: Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004, 34:9-19.
6. Nanji AA: Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. Alcohol 2004, 34:21-25.
7. Polavarapu R, Spitz DR, Sim JE, Follansbee MH, Oberley LW, Rahemtulla A, Nanji AA: Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 1998, 27:1317-1323.
8. Sies H: Strategies of antioxidant defense. Eur J Biochem 1993, 215:213-219.
9. Thiele GM, Freeman TL, Klassen LW: Immunologic mechanisms of alcoholic liver injury. Semin Liver Dis 2004, 24:273-287.
10. Laso FJ, Iglesias-Osma C, Ciudad J, Lopez A, Pastor I, Torres E, Orfao A: Alcoholic liver cirrhosis is associated with a decreased expression of the CD28 costimulatory molecule, a lower ability of T cells to bind exogenous IL-2, and increased soluble CD8 levels. Cytometry 2000, 42:290-295.
11. Pruett SB, Schwab C, Zheng Q, Fan R: Suppression of innate immunity by acute ethanol administration: a global perspective and a new mechanism beginning with inhibition of signaling through TLR3. J Immunol 173:2715-2724. 8-15-2004
12. Afford SC, Fisher NC, Neil DA, Fear J, Brun P, Hubscher SG, Adams DH: Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol 1998, 186:82-89.
13. Bautista AP: Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease. J Gastroenterol Hepatol 2000, 15:349-356.
14. Maltby J, Wright S, Bird G, Sheron N: Chemokine levels in human liver homogenates: associations between GRO alpha and histopathological evidence of alcoholic hepatitis. Hepatology 1996, 24:1156-1160.
15. Mosher B, Dean R, Harkema J, Remick D, Palma J, Crockett E: Inhibition of Kupffer cells reduced CXC chemokine production and liver injury. J Surg Res 2001, 99:201-210.
16. Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K: The role of liver biopsy in chronic hepatitis C. Hepatology 2001, 33:196-200.
17. Bieche I, Asselah T, Laurendeau I, Vidaud D, Degot C, Paradis V, Bedossa P, Valla DC, Marcellin P, Vidaud M: Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology 2005, 332:130-144.
18. Smith MW, Walters K-A, Korth MJ, Fitzgibbon M, Proll SC, Thompson JC, Yeh MM, Shuhart MC, Furlong JC, Cox PP, Thomas DL, Phillips JD, Kushner JP, Fausto N, Carithers RL, Katze MG: Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients. Gastroenterol 2006, 130:179-187.
19. Walters KA, Joyce MA, Thompson JC, Smith MW, Yeh MM, Proll S, ZhuLin-Fu Gao TJ, Knetman NM, Tyrrell DL, Katze MG: Host-Specific Response to HCV Infection in the Chimeric SCID-beige/Alb-uPA Mouse Model: Role of the Innate Antiviral Immune Response. PLOS Pathogens 2:591-601. 6-23-2006
20. Yamaguchi A, Tazuma S, Nishioka T, Ohishi W, Hyogo H, Nomura S, Chayama K: Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver. Dig Dis Sci 2005, 50:1361-1371.
21. Baas T, Taubenberger J, Chong PY, Chui P, Katze MG: SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues. J Interferon Cytokine Res 2006, 26:309-317.
22. Korth MJ, Kash JC, Baskin CR, Katze MG: Insights into influenza virus-host interactions through global gene expression profiling: cell culture systems to animal models. 2006:341-360.
23. Kash JC, Mühlberger E, Carter V, Grosch O, Perwitasari O, Proll SC, Thomas MJ, Weber F, Klenk H.-D, Katze MG: Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type 1 interferon response is associated with enhanced virulence. J Virol 2006, 80:3009-3020.
24. Korth MJ, Kash JC, Furlong JC, Katze MG: Virus infection and the interferon response: a global view through functional genomics. Methods Mol Med 2005, 116:37-55.
25. Uchimura Y, Sata M, Kage M, Abe H, Tanikawa K: A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. Liver 1995, 15:300-306.
26. Nuti S, Rosa D, Valiante NM, Saletti G, Caratozzolo M, Dellabona P, Barnaba V, Abrignani S: Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 1998, 28:3448-3455.
27. Laso FJ, Madruga JI, Lopez A, Ciudad J, varez-Mon M, San Miguel J, Orfao A: Distribution of peripheral blood lymphoid subsets in alcoholic liver cirrhosis: influence of ethanol intake. Alcohol Clin Exp Res 1996, 20:1564-1568.
28. Chedid A, Mendenhall CL, Moritz TE, French SW, Chen TS, Morgan TR, Roselle GA, Nemchausky BA, Tamburro CH, Schiff ER: Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275. Gastroenterology 1993, 105:254-266.
29. Chiang JY: Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J Hepatol 2004, 40:539-551.
30. Koop DR, Tierney DJ: Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1. Bioessays 1990, 12:429-435.
31. Takahashi T, Lasker JM, Rosman AS, Lieber CS: Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology 1993, 17:236-245.
32. Bigger CB, Brasky KM, Lanford RE: DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 2001, 75:7059-7066.
33. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD: Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992, 149:3339-3344.
34. Cerny A, Chisari FV: Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999, 30:595-601.
35. Smith MW, Yue ZN, Korth MJ, Do HA, Boix L, Fausto N, Bruix J, Carithers RL Jr, Katze MG: Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers. Hepatology 2003, 35:1458-1467.
36. Mueller T, Mas-Marques A, Sarrazin C, Wiese M, Halangk J, Witt H, Ahlenstiel G, Spengler U, Goebel U, Wiedenmann B, Schreier E, Berg T: Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection. J Hepatol 2004, 41:652-658.
37. Nascimbeni M, Shin EC, Chiriboga L, Kleiner DE, Rehermann B: Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functions. Blood 2004, 104:478-486.
38. Leroy V, Vigan I, Mosnier JF, Dufeu-Duchesne T, Pernollet M, Zarski JP, Marche PN, Jouvin-Marche E: Phenotypic and functional characterization of intrahepatic T lymphocytes during chronic hepatitis C. Hepatology 2003, 38:829-841.
39. Kusano F, Tanaka Y, Marumo F, Sato C: Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C. Lab Invest 2000, 80:415-422.
40. McCaughan GW, Gorrell MD, Bishop GA, Abbott CA, Shackel NA, McGuinness PH, Levy MT, Sharland AF, Bowen DG, Yu D, Slaitini L, Church WB, Napoli J: Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunol Rev 2000, 174:172-191.
41. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughan GW: Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996, 24:759-765.
42. Cook RT: Alcohol abuse, alcoholism, and damage to the immune system - a review. Alcohol Clin Exp Res 1998, 22:1927-1942.
43. Zhang Z, Bagby GJ, Stoltz D, Oliver P, Schwarzenberger PO, Kolls JK: Prolonged ethanol treatment enhances lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-alpha production in human monocytic cells. Alcohol Clin Exp Res 2001, 25:444-449.
44. Pritchard MT, Nagy LE: Ethanol-induced liver injury: potential roles for egr-1. Alcohol Clin Exp Res 2005, 29:146S-150S.
45. Takeyama Y, Kamimura S, Kuroiwa A, Sohda T, Irie M, Shijo H, Okumura M: Role of Kupffer cell-derived reactive oxygen intermediates in alcoholic liver disease in rats in vivo. Alcohol Clin Exp Res 1996, 20:335A-339A.
46. Neuman MG, Brenner DA, Rehermann B, Taieb J, Chollet-Martin S, Cohard M, Garaud JJ, Poynard T, Katz GG, Cameron RG, Shear NH, Gao B, Takamatsu M, Yamauchi M, Ohata M, Saito S, Maeyama S, Uchikoshi T, Toda G, Kumagi T, Akbar SM, Abe M, Michitaka K, Horiike N, Onji M: Mechanisms of alcoholic liver disease: cytokines. Alcohol Clin Exp Res 2001, 25:251S-253S.
47. Thurman RG: II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 1998, 275:G605-G611.
48. Bataller R, Sancho-Bru P, Gines P, Brenner DA: Liver fibrogenesis: a new role for the renin-angiotensin system. Antioxid Redox Signal 2005, 7:1346-1355.
49. Memon RA, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR: In vivo and in vitro regulation of sterol 27-hydroxylase in the liver during the acute phase response. potential role of hepatocyte nuclear factor-1. J Biol Chem 2001, 276:30118-30126.
50. Koivisto T, Mishin VM, Mak KM, Cohen PA, Lieber CS: Induction of cytochrome P-4502E1 by ethanol in rat Kupffer cells. Alcohol Clin Exp Res 1996, 20:207-212.
51. Expression Array Manager [http://expression.microslu.washington.edu/ expression/index.html]
52. Geiss GK, An MC, Bumgarner RE, Hammersmark E, Cunningham D, Katze MG: Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. J Virol 2001, 75:4321-4331.
53. Smith MW, Yue ZN, Geiss GK, Sadovnikova NY, Carter VS, Boix L, Lazaro CA, Rosenberg GB, Bumgarner RE, Fausto N, Bruix J, Katze MG: Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. Cancer Res 2003, 75:859-864.
54. Geiss GK, Carter VS, He Y, Kwieciszewski BK, Holzman T, Korth MJ, Lazaro CA, Fausto N, Bumgarner RE, Katze MG: Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein. J Virol 2003, 77:6367-6375.
55. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FCP, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M: Minimum information about a microarray experiment (MIAME) toward standards for microarray data. Nature Genet 2001, 29:365-371.
56. Fatigo [http://fatigo.bioinfo.cipf.es]
57. Ingenuity Systems [http://ingenuity.com]